NCT01378871 2023-06-09
A Phase II Study Of Imtox-25 In Adults With Refractory/Relapsed Cd25 Positive Adult T Cell Leukemia/Lymphoma
Albert Einstein College of Medicine
Phase 2 Terminated
Clinical Trials
1 trialsTerminated × Precursor T-Cell Lymphoblastic Leukemia-Lymphoma × RFT5-SMPT-dgA immunotoxin × Clear all